title: Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
abstract: The changes in blood volume (BV), atrial natriuretic peptide (ANP), plasma renin activity (PRA), aldosterone (Aldo), norepinephrine (NE), epinephrine (Epi), parathyroid hormone (PTH), arginine vasopressin (AVP) and the cyclic nucleotides cAMP and cGMP were measured during a fluctuating BV cycle in 15 patients with end-stage renal failure maintained on chronic hemodialysis (HD). HD consisted of 4 periods of about 60 min each. The first half of each HD period consisted of ultrafiltration (UF) greater than 1,000 ml/h, and the second half consisted of no UF. Changes in relative BV were measured using continuous hemoglobinometry. Total BV at the end of treatment was 74.3 +/- 6.9% of the pretreatment volume. A significant positive correlation between BV and the levels of ANP, PTH, Epi and cGMP and an inverse correlation between BV and PRA, Aldo, AVP and NE were demonstrated. While mean values of NE and AVP levels were directly related to actual changes in BV, individual values did not homogeneously reflect this relationship. The cyclic nucleotides cGMP and cAMP did not follow immediate BV changes, but showed a significant decrease correlated with diminished BV. Based on a pre-postdialysis analysis, significant changes in PRA and Aldo were missing. It seems possible that vascular stability in dialysis patients may be maintained by the response of NE and AVP, and not by the renin-aldosterone system. The changes in ANP and cGMP values correlated most significantly (r = 0.38 and r = 0.51, p < 0.005) with the changes in BV, but no single variable could explain the blood pressure regulation during HD with intermittent rapid UF.
authors.affiliation: 2nd Medical Clinic, Technical University of Aachen, FRG.
authors.forename: B
authors.initials: B
authors.lastname: Heintz
authors.forename: F
authors.initials: F
authors.lastname: Königs
authors.forename: K V
authors.initials: KV
authors.lastname: Dakshinamurty
authors.forename: H
authors.initials: H
authors.lastname: Kierdorf
authors.forename: U
authors.initials: U
authors.lastname: Gladziwa
authors.forename: R
authors.initials: R
authors.lastname: Kirsten
authors.forename: K
authors.initials: K
authors.lastname: Nelson
authors.forename: D
authors.initials: D
authors.lastname: Wieland
authors.forename: J
authors.initials: J
authors.lastname: Riehl
authors.forename: H
authors.initials: H
authors.lastname: Mann
mesh_terms: D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D001127:Arginine Vasopressin / Q000097:blood; D009320:Atrial Natriuretic Factor / Q000097:blood; D001794:Blood Pressure / Q000502:physiology*; D001810:Blood Volume / Q000502:physiology*; D000242:Cyclic AMP / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000502:physiology; D017583:Hemodiafiltration; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis; D012083:Renin / Q000097:blood; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000097:blood*
chemical_list: D010281:Parathyroid Hormone; D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP; D012083:Renin; D006152:Cyclic GMP; D009638:Norepinephrine; D004837:Epinephrine